A detailed history of Arizona State Retirement System transactions in Avid Bioservices, Inc. stock. As of the latest transaction made, Arizona State Retirement System holds 18,309 shares of CDMO stock, worth $225,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares
18,309
Previous 17,704 3.42%
Holding current value
$225,200
Previous $126,000 65.08%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$6.7 - $12.45 $4,053 - $7,532
605 Added 3.42%
18,309 $208,000
Q2 2024

Aug 05, 2024

BUY
$6.34 - $9.28 $2,054 - $3,006
324 Added 1.86%
17,704 $126,000
Q1 2024

May 07, 2024

SELL
$5.86 - $8.79 $1,541 - $2,311
-263 Reduced 1.49%
17,380 $116,000
Q4 2023

Jan 24, 2024

SELL
$4.64 - $9.56 $1,011 - $2,084
-218 Reduced 1.22%
17,643 $114,000
Q3 2023

Nov 06, 2023

BUY
$9.4 - $14.04 $2,754 - $4,113
293 Added 1.67%
17,861 $168,000
Q2 2023

Aug 01, 2023

SELL
$12.96 - $20.93 $5,767 - $9,313
-445 Reduced 2.47%
17,568 $245,000
Q1 2023

Apr 27, 2023

BUY
$13.48 - $18.79 $6,349 - $8,850
471 Added 2.68%
18,013 $337,000
Q4 2022

Feb 07, 2023

BUY
$12.61 - $18.74 $9,621 - $14,298
763 Added 4.55%
17,542 $241,000
Q3 2022

Nov 07, 2022

BUY
$15.33 - $20.36 $1,379 - $1,832
90 Added 0.54%
16,779 $321,000
Q2 2022

Jul 28, 2022

BUY
$11.63 - $21.55 $1,244 - $2,305
107 Added 0.65%
16,689 $255,000
Q1 2022

May 04, 2022

BUY
$16.63 - $27.73 $1,197 - $1,996
72 Added 0.44%
16,582 $338,000
Q4 2021

Feb 04, 2022

SELL
$20.7 - $34.18 $1,221 - $2,016
-59 Reduced 0.36%
16,510 $482,000
Q3 2021

Nov 12, 2021

BUY
$19.05 - $28.32 $647 - $962
34 Added 0.21%
16,569 $357,000
Q2 2021

Aug 02, 2021

BUY
$18.93 - $25.65 $313,007 - $424,122
16,535 New
16,535 $424,000

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $765M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Arizona State Retirement System Portfolio

Follow Arizona State Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arizona State Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on Arizona State Retirement System with notifications on news.